(Q44282392)

1 December 2017

Early events in proton pump inhibitor-associated exacerbation of corpus gastritis (English)

1 reference

1 December 2017

1

Graham DY

1 reference

1 December 2017

Opekun AR

2

1 reference

1 December 2017

Yamaoka Y

series ordinal

3

1 reference

1 December 2017

Osato MS

series ordinal

4

1 reference

1 December 2017

el-Zimaity HM

series ordinal

5

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

Alimentary Pharmacology & Therapeutics

1 December 2017

1 reference

1 December 2017

17

1 reference

1 December 2017

2

1 reference

1 December 2017

193-200

1 reference

Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication

1 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01400.X

Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01400.X

Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01400.X

Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01400.X

Effect of Helicobacter pylori infection on gastric juice pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01400.X

Long-term lansoprazole treatment for gastro-oesophageal reflux disease: clinical efficacy and influence on gastric mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01400.X

Atrophic gastritis during long-term omeprazole therapy affects serum vitamin B12 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01400.X

Quantitative assessment of gastric corpus atrophy in subjects using omeprazole: a randomized follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01400.X

Antagonist: Should we eradicate Helicobacter pylori before long term antireflux therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01400.X

Protagonist: Should we eradicate Helicobacter pylori before long term antireflux therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01400.X

Proton pump inhibitor modifies inflammatory reaction in human gastric mucosa infected by Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01400.X

Patterns of gastric atrophy in intestinal type gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01400.X

Gastric intestinal metaplasia: subtypes and natural history

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01400.X

Helicobacter pylori infection and the development of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01400.X

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01400.X

Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01400.X

Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during and after 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01400.X

H2-receptor antagonists and antacids have an aggravating effect on Helicobacter pylori gastritis in duodenal ulcer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01400.X

Changing Patterns of Helicobacter pylori Gastritis in Long-Standing Acid Suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01400.X

Eradication of Helicobacter pylori heals atrophic corpus gastritis caused by long-term treatment with omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01400.X

Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during long-term acid-suppressive treatment in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01400.X

Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01400.X

Twice a day quadruple therapy (bismuth subsalicylate, tetracycline, metronidazole plus lansoprazole) for treatment of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01400.X

10.1046/J.1365-2036.2003.01400.X

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference